SC 13G Filing

Company

Medicenna Therapeutics Corp.

Filed

October 20, 2022

Accession Number

0001493152-22-028941

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →